innovations during the drug
discovery phase.
We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.
We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.
Scott Rettig has more than 20 years of experience in the Biotech, Pharmaceutical, and Life Sciences industries focusing in the areas of GMP and GLP. He has held various individual contributor and management roles with increased complexity and responsibilities throughout his career within GMP Manufacturing, GMP Analytical Development, GLP Pre-Clinical Development, and global GxP Scientific Compliance. Scott’s expertise is working with GxP clients to design, develop, and improve quality systems and business processes, investigating opportunities to transition manual processes to electronic system processes, fit-for-purpose compliance remediation, inspection readiness, and team development.
Before joining Halloran, Scott was the Associate Director of Global Scientific Compliance at AbbVie, a global pharmaceutical company, where he led a team of 10 compliance specialists and multiple project-scoped contract employees. He developed and provided oversight of aligned strategies for the development, maintenance, and implementation of global business processes and quality procedures providing fit-for-purpose and efficient compliance to meet regulatory requirements and satisfy internal procedures. He was responsible for scientific publication management/submission, regulatory and quality intelligence triage, and impact assessment, quality system document change control and strategy, learning/training management strategy and implementation, laboratory instrument system lifecycle compliance, audit/inspection support and response, exception/CAPA management, and organizational alignment/integration following mergers and acquisitions. He also partnered with QA units and cross-functional teams to develop and implement a compliance strategy to support the creation of a new independent CLIA-certified laboratory to support COVID-19 patient sample testing during the 2020 Illinois health emergency.
Before that, Scott served two different GxP roles at Bristol-Myers Squibb, a global pharmaceutical company. He was a Research Scientist/Lab Manager where he managed a formulation laboratory team supporting nonclinical GLP toxicology safety studies within the R&D GLP Drug Safety Evaluation organization. He also worked in pharmaceutical product commercial manufacturing as a Team Leader where he managed both a compounding, tableting, and coating operations cell for solid dosage forms and a consumer bottle packaging group in finished goods packaging. Before that, Scott held leadership and individual contributor positions at Large Scale Biology Corporation and Sigma-Aldrich, focusing on manufacturing processes and analytical support.
University of Evansville, Bachelor of Science, Biology and Chemistry
University of Southern Indiana, Certificate, Factory Physics